Dr. Eric J Grigsby, M.D. Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3434 Villa Ln, Suite 150, Napa, CA 94558 Phone: 707-252-9666 Fax: 707-258-2780 |
News Archive
The Association of American Physicians and Surgeons (AAPS) became the first medical society to sue to overturn the newly enacted health care bill, the Patient Protection and Affordable Care Act (PPACA). AAPS sued Friday in the U.S. District Court for the District of Columbia (AAPS v. Sebelius et al.).
Implantable pacemakers have without doubt altered modern medicine, saving countless lives by regulating heart rhythm. But they have one serious shortcoming: Their batteries last only five to 12 years, at which point they have to be replaced surgically.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy that would improve median overall survival over IFL (bolus 5-fluorouracil, generics/leucovorin, generics/irinotecan*) plus bevacizumab (Roche/Genentech/Chugai's Avastin), would earn a 60 percent patient share in stage IV colorectal cancer, according to surveyed U.S. oncologists. In Europe, such an agent would earn a 50 percent patient share, according to surveyed European oncologists.
Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania's Abramson Cancer Center during the 2015 Genitourinary Cancers Symposium.
› Verified 7 days ago